Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.19.1
Consolidated Balance Sheets - USD ($)
Feb. 28, 2019
Nov. 30, 2018
Current Assets    
Cash and cash equivalents $ 7,075,691 $ 6,040,033
Marketable securities 808,510 875,689
Accounts receivable (net of allowance for doubtful accounts of $2,368,309 and $2,264,848, respectively) 5,694,162 5,867,335
Prepaid expenses 460,554 461,815
Inventory, net 16,132,585 16,035,873
Other current assets 204,895 254,465
Total current assets 30,376,397 29,535,210
Property and Equipment-net 1,464,511 1,493,401
Other Assets    
Intangible assets, net 1,314,441 1,341,336
Goodwill 1,941,411 1,941,411
Deferred tax assets 7,562,705 7,656,897
Deposits and other assets, net 374,869 113,888
Total other assets 11,501,426 11,361,532
Total assets 43,342,334 42,390,143
Current Liabilities    
Accounts payable 1,010,392 1,261,653
Accrued expenses 2,901,600 2,702,788
Current portion of note payable 3,100,000 3,100,000
Deferred revenue 8,266,997 8,365,284
Total current liabilities 15,278,989 15,429,725
Other Liabilities    
Deferred revenue, net of current portion 21,124,200 20,317,231
Contingent consideration 4,650,032 4,282,975
Note payable, net of current portion and debt issuance costs 9,098,405 9,843,510
Long-term liability - revenue sharing agreements 1,425,000 1,425,000
Total other liabilities 36,297,637 35,868,716
Total liabilities 51,576,626 51,298,441
Commitments and contingencies (Note 10)
Stockholders' Deficit    
Preferred stock
Common stock ($.01 par value, 20,000,000 authorized; 13,598,909 issued and 7,803,333 outstanding as of February 28, 2019 and 13,596,409 issued and 7,800,833 outstanding as of November 30, 2018) 135,989 135,964
Additional paid-in capital 35,660,039 35,515,382
Treasury stock, at cost (19,571,113) (19,571,113)
Accumulated other comprehensive income   340,984
Accumulated deficit (24,459,207) (25,329,515)
Total stockholders' deficit (8,234,292) (8,908,298)
Total liabilities and stockholders' deficit 43,342,334 42,390,143
Series A Junior Participating Preferred Stock [Member]    
Stockholders' Deficit    
Preferred stock
Tianhe Stem Cell Biotechnologies Inc [Member]    
Other Assets    
Investment $ 308,000 $ 308,000